| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.34 | 3e-20 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-19 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-18 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 5e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |